Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08OJU
|
||||
Former ID |
DIB009432
|
||||
Drug Name |
SOU-001
|
||||
Synonyms |
AA-10020; DRP-001
|
||||
Indication | Urinary incontinence [ICD9: 788.3; ICD10:N39.3, N39.4, R32] | Discontinued in Phase 2 | [547251] | ||
Company |
Arachnova Therapeutics Ltd
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1B adrenergic receptor | Target Info | Modulator | [527154] | |
Alpha-1A adrenergic receptor | Target Info | Modulator | [527154] | ||
Alpha-1D adrenergic receptor | Target Info | Modulator | [527154] | ||
NetPath Pathway | IL2 Signaling PathwayNetPath_14:IL2 Signaling Pathway | ||||
Pathway Interaction Database | LPA receptor mediated events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.